China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on Guiding Precision Therapy via Tumor Organoid Drug Sensitivity Testing'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135571
Registration Time: 2026/10/30
Type: Observational study
Primary Sponsor: The Second Affiliated hospital of Fujian Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348988
Published by HT Digital Content Services with permission from Health Daily Digest....